Updated:
Surgical.ai
Surgical.ai is a Berlin-based investment firm focused solely on surgical robotics and AI-driven medtech ventures.
Surgical.ai
Surgical.ai operates out of Berlin, channeling capital into early-stage ventures that bring automation and machine learning to surgery. The firm's mandate focuses on the intersection of robotics, data science, and clinical procedure — a deliberately narrow aperture across medtech. The firm's investment strategy spans direct equity stakes in surgical robotics platforms, AI-driven intraoperative guidance software, and novel instrumentation. Active positions target companies commercializing autonomous tissue manipulation, augmented-reality surgical navigation, and predictive analytics for patient-specific pre-operative planning. The firm pursues a concentrated, hands-on approach, leading or co-leading rounds and taking board seats when possible. The scale of Surgical.ai's operations and the size of its team are not publicly disclosed. The firm maintains its sole office in Berlin, supporting a portfolio that extends across Europe and North America. No adjacent philanthropic vehicles, real-asset arms, or operating companies are known. Surgical.ai's structural distinction lies in its singular technological thesis. Rather than backing a broad spectrum of healthcare services, diagnostics, or biopharma, the firm's entire mandate rests on the belief that the surgical suite is the next frontier for fully autonomous systems. This concentrated risk posture, combined with a European headquarters in a field often dominated by US-based venture capital, shapes its sourcing and partnering dynamics.
General information
Firm type
Generalist
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Germany
City
Berlin
Corporate office
Berlin, Germany
Sector focus
Frequently asked questions
What is Surgical.ai's investment thesis?
Surgical.ai bets exclusively on companies that integrate robotics, artificial intelligence, and surgical procedure. The firm views the operating room as a distinct technological environment and backs ventures building autonomous systems, augmented-reality guidance, and patient-specific surgical software. It does not invest in broader healthcare services, diagnostics, or biopharma.
Does Surgical.ai take board seats in its portfolio companies?
Surgical.ai pursues a concentrated, hands-on approach and will take board seats when possible. The firm typically leads or co-leads investment rounds in the surgical technology companies it backs.
Is Surgical.ai a single family office or a venture capital firm?
Surgical.ai is structured as an asset manager with a generalist mandate, functioning as a thematic venture investor. It does not publicly identify as a single family office. The source and origin of its capital are not publicly disclosed.
Which sectors does Surgical.ai explicitly avoid?
Surgical.ai avoids all healthcare verticals outside the surgical suite. It does not invest in general digital health, diagnostics, biopharma, or healthcare services delivery. Its commitment is to technologies that physically or digitally interact with the patient during a procedure.
Where does Surgical.ai invest geographically?
The firm invests in portfolio companies across Europe and North America. Its own operations remain headquartered solely in Berlin, Germany.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: